HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capital market and should be the eleventh 18A Biotech company listed in

SANTA MONICA, Calif., Nov. 7, 2019 /PRNewswire/ -- PatientPop, the leader in healthcare practice growth technology, has received

BUFFALO GROVE, Ill., Nov. 7, 2019 /PRNewswire/ -- Leica Microsystems Inc., a developer and manufacturer of microscopes and scientific instruments for the analysis of microstructures and nanostructures, and Cameron Ehlen Group, d/b/a Precision Lens ("Precision Lens"), have signed an exclusive distribution agreement. Precision Lens, which sells and distributes intraoc

CAMBRIDGE, Mass., Nov. 7, 2019 /PRNewswire/ -- Arkuda Therapeutics, a company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease, today announced the completion of a $44 million Series A financing. Led by a team of drug developers and scientists with deep

CLEVELAND, Nov. 7, 2019 /PRNewswire/ -- GenomOncology, LLC (GO) announced today that it was selected by the Duke Cancer Institute to utilize GO's Precision Oncology Platform to provide real-time therapeutic, prognostic, and clinical trial recommendations to molecular tumor board organizers and participants at Duke Cancer Institute. Duke will l

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactiguard's technology in a global perspective and a new medical applicatio

BERGEN, Norway, Nov. 7, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), will announce its results for the third quarter on Tuesday 19 November 2019. A presentation by BerGenBio's senior management team will take place at 10am CET at:Arctic Securities Haakon VIIs gate 5

OSLO, Norway, Nov. 7, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2019 results.A meeting for investors, analysts and press will take place in Oslo today at 1

SUZHOU, China, Nov. 6, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that an abstract on the CS1001-201 trial (Abstract #2833) was accepted by the 2019 American Society of Hematology (ASH) Annual Meeting and has been published online yesterday on the meeting's official website. Additionally, the Company will release f

MIAMI GARDENS, Fla., Nov 6, 2019 /PRNewswire/ -- Skin & Cancer Associates (SCA), the first dermatology practice management group in Florida, is excited to announce the dermatology practice and research institute of Dr. Leslie Baumann - Baumann Cosmetic Research Institute (BCRI) - joined the SCA team